Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of Hydroxychloroquine Sulfate for Reduction of Proteinuria in Patients With IgA Nephropathy

NCT02942381 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.

NCT NCT02942381
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02942381 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of Hydroxychloroquine Sulfate for Reduction of Proteinuria in Patients With IgA Nephropathy
Lead sponsor
Peking University First Hospital
Phase
Phase 2
Overall status
Completed
Start date
September 13, 2016
Completion date
January 8, 2018
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hydroxychloroquine, iga patients